×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| BIOCON LTD. | 38562 | 811 | 38214 | 0.21 | 38,714 | 47.0 |
| GLENMARK PHARMACEUTICALS LTD. | 34186.8 | 3480.31 | 33875.52 | 12.33 | 36706 | 15.9 |
| IPCA LABORATORIES LTD. | 16,800.90 | 2,675.60 | 16,626.80 | 10.55 | 36659 | 49.9 |
Biocon Ltd., with Security Code 532523, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 441.7 | 489.5 | 555.0 | 506.7 | 513.2 | 518.7 | 562.8 | 532.6 | 510.6 | 525.4 |
| Expenses | 439.1 | 461.7 | 517.9 | 550.7 | 441.2 | 451.5 | 491.5 | 480.4 | 465.7 | 487.8 |
| Operating Profit | 2.6 | 27.8 | 37.1 | -44.0 | 72.0 | 67.2 | 71.3 | 52.2 | 44.9 | 37.6 |
| OPM % | 0.59% | 5.68% | 6.68% | -8.68% | 14.03% | 12.96% | 12.67% | 9.8% | 8.79% | 7.16% |
| Other Income | 48.6 | 1,108.1 | 59.9 | 1,917.6 | 55.7 | 64.4 | 48.5 | 38.9 | 41.9 | 73.5 |
| Interest | 0.1 | 0.0 | 21.4 | 48.1 | 48.3 | 55.0 | 56.0 | 39.5 | 55.2 | 59.7 |
| Depreciation | 28.6 | 29.8 | 29.1 | 29.4 | 29.8 | 30.6 | 30.9 | 29.8 | 30.5 | 30.5 |
| Profit before tax | 22.5 | 96.9 | 46.5 | -57.5 | 29.9 | 51.2 | 32.9 | 21.8 | 1.1 | 20.9 |
| Tax % | 33.8% | 10.7% | 24.3% | 0.8% | 6% | 24.6% | 27.1% | 35.8% | 18.2% | 84.7% |
| Net Profit | 14.9 | 987.5 | 35.2 | 1,810.8 | 46.6 | 34.7 | 24.0 | 14.0 | 0.9 | 3.2 |
| EPS in Rs | 0.12 | 8.26 | 0.29 | 15.14 | 0.39 | 0.29 | 0.2 | 0.12 | 0.01 | 0.03 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,319.7 | 2,941.1 | 3,773.9 | 3,422.6 | 3,462.3 | 3,953.7 | 3,917.1 | 3,432.9 | 3,590.4 | 3,821.4 |
| Expenses | 1,877.3 | 2,352.4 | 2,816.7 | 2,741.4 | 2,744.9 | 3,051.0 | 3,003.9 | 2,812.5 | 2,905.0 | 3,069.6 |
| Operating Profit | 442.4 | 588.7 | 957.2 | 681.2 | 717.4 | 902.7 | 913.2 | 620.4 | 685.4 | 751.8 |
| OPM % | 19.1% | 20% | 25.4% | 19.9% | 20.7% | 22.8% | 23.3% | 18.1% | 19.1% | 19.7% |
| Other Income | 47.5 | -192.8 | 151.9 | 93.5 | 133.9 | 586.7 | 39.8 | 1,166.5 | 58.5 | 52.9 |
| Interest | 30.0 | 120.3 | 248.8 | 233.0 | 247.7 | 266.7 | 227.0 | 236.0 | 225.6 | 223.4 |
| Depreciation | 230.8 | 301.1 | 363.7 | 358.0 | 389.3 | 414.5 | 407.0 | 405.4 | 419.9 | 425.4 |
| Profit before tax | 246.1 | 245.9 | 499.6 | 183.7 | 238.3 | 787.0 | 327.8 | 1,113.5 | 72.4 | 137.8 |
| Tax % | 57.2% | 15.9% | 15.3% | 16% | 17.4% | 6.6% | 29.9% | 24.8% | 72.5% | 48% |
| Net Profit | 81.8 | -20.7 | 414.5 | 148.9 | 172.7 | 753.3 | 222.9 | 861.8 | 27.1 | 81.1 |
| EPS in Rs | 0 | 0 | 2 | 0 | 1 | 5 | 1 | 5 | 0 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 4% |
| 3 Years: | 2% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -11% |
| 5 Years: | -20% |
| 3 Years: | -27% |
| TTM: | -70% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| 1 Year: | 19% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 22% |
| 3 Years: | 27% |
| TTM: | 1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 6% |
| 3 Years: | 11% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 0% |
| 3 Years: | -6% |
| 1 Year: | 19% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|